Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

Name: Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
License: Public Domain

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

mesothelioma, malignant, pd-l1 negative, advanced cancer, progressive disease

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 217104
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.